Home > Clinical Trials

Saved trials

Terminated
NCT05091528
A Safety and Activity Study of SBT6050 in Combination With Other HER2-directed Therapies for HER2-positive Cancers
2 Enrollment(s)
1 Study location(s)
Interventional (Phase I|Phase II)
HER2-positive Breast Cancer
HER2-positive Gastric Cancer
HER2-positive Colorectal Cancer
HER2-expressing Non-small Cell Lung Cancer
Active, not recruiting
NCT03895502
Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Study
605 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Venous Thrombosis
Neoplasms
Anticoagulant
Completed
NCT03247582
Edoxaban Treatment in Routine Clinical Practice for Patients With Non-valvular Atrial Fibrillation (ETNA-AF-Hong Kong)
234 Enrollment(s)
4 Study location(s)
Observational
Atrial Fibrillation
Recruiting
NCT05189015
Effect of Olmesartan on Angiotensin(1-7) Levels and Vascular Functions in Diabetes and Hypertension
80 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Angiotensin/Renin/Aldosterone Hypertension
Hypertension
Diabetes Mellitus, Type 2
Completed
NCT03524924
Edoxaban and Frailty in Senior Individuals
180 Enrollment(s)
1 Study location(s)
Observational
Atrial Fibrillation
Active, not recruiting
NCT05491460
Pharmacokinetics and Point of Care Testing of Direct Oral Anticoagulants Subjects
24 Enrollment(s)
1 Study location(s)
Interventional (Phase I)
Anticoagulant Therapy
Recruiting
NCT03148457
Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
2,000 Enrollment(s)
98 Study location(s)
Interventional (Not Applicable)
Ischaemic Stroke
Completed
NCT03723681
Study of Quizartinib in Combination With Standard Therapies in Chinese Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
7 Enrollment(s)
1 Study location(s)
Interventional (Phase I)
Acute Myeloid Leukemia (AML)